M&A Deal Summary |
|
---|---|
Date | 2012-12-01 |
Target | Douglas |
Sector | Retail |
Buyer(s) | Advent International |
Deal Type | Going Private |
Deal Value | 1.9B USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1984 |
PE ASSETS | 76.0B USD |
Size | Mega |
Type | Sector Agnostic |
Advent is a global private equity firm that targets investments in North America, Europe, Asia, and Latin America. Advent's emerging market efforts are concentrated in Central Europe and Latin America. Advent seeks transactions valued between $50 million and $5 billion and can commit up to $2 billion of equity capital per investment. Broad areas of interest include business & financial services, retail & consumer, technology, media, & telecoms, healthcare & life sciences, and industrial. Prospective transaction types include buyouts, growth capital financings, take privates, and recapitalizations. Advent was formed in 1984 and is based in Boston, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 204 of 341 |
Sector (Retail) | 19 of 20 |
Type (Going Private) | 7 of 19 |
Country (Germany) | 14 of 22 |
Year (2012) | 9 of 9 |
Size (of disclosed) | 17 of 47 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2012-11-16 |
Xafinity
Crawley, United Kingdom Xafinity provides consulting, software, resourcing, training and business process outsourcing services that enable public and private sector organisations to deliver employee benefits more efficiently. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2012-12-31 |
LaborMed Pharma
Ljubljana, Romania LaborMed Pharma is a manufacturer and distributor generic pharmaceuticals primarily for cardiovascular and central nervous system aliments. The Company has also launched a portfolio of drugs for diabetes. LaborMed Pharma is based in Ljubljana, Romania. |
Sell | - |